Related Experiment Videos

Prospective study of cardiac troponin I release in patients with upper gastrointestinal bleeding

David M Iser1, Alexander J V Thompson, Koon Ket Sia

  • 1Department of Medicine, The University of Melbourne, Western Hospital, Melbourne, Victoria, Australia. david.iser@svhm.org.au

Insights

Acute upper gastrointestinal bleeding carries a significant risk of cardiac injury, with up to 19% of patients experiencing troponin release. This cardiac damage screening is crucial, particularly for elderly patients with hemodynamic instability.

Area of Science:

  • Cardiology
  • Gastroenterology
  • Internal Medicine

Background:

  • The incidence of cardiac injury in patients with upper gastrointestinal hemorrhage is not well-established.
  • Acute upper gastrointestinal bleeding (UGIB) can precipitate cardiac events.

Purpose of the Study:

  • To prospectively assess the risk of cardiac troponin I release in patients with acute UGIB.
  • To identify adverse cardiac events associated with UGIB.

Main Methods:

  • Prospective study of 156 patients with hematemesis or melena.
  • Serial cardiac troponin I assays at 0, 12, and 24 hours.
  • Monitoring of creatine kinase levels, electrocardiograms, and clinical data.

Main Results:

  • 19% of patients (30/156) showed elevated troponin levels (>0.5 microg/L) within 24 hours.
  • Factors associated with troponin release included age >65, hemodynamic instability, history of cardiac disease, post-endoscopy compromise, and re-bleeding.
  • 81% of patients had normal troponin levels.

Conclusions:

  • Upper gastrointestinal bleeding is linked to a cardiac injury risk of up to 19%.
  • Cardiac troponin assays can effectively screen for cardiac damage in UGIB patients.
  • Screening is particularly important for elderly patients presenting with hemodynamic instability.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...